Moderna | MRNA - Ordinary Share Capital


Moderna reported $391M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 171.09M 1.9M Mar/2026
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Alnylam Pharmaceuticals USD 133.73M 290K Jun/2026
Amgen USD 541M 1000K Jun/2026
Arrowhead Research USD 141.14M 564K Jun/2026
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.54M 267K Jun/2026
Celltrion KRW 229.65M 11.03M Mar/2026
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 54.58M 11.36M Mar/2026
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Gilead Sciences USD 1.24B 1000K Jun/2026
GlaxoSmithKline GBP 4.08B 20.6M Jun/2026
Incyte USD 200.98M 1.03M Jun/2026
Ionis Pharmaceuticals USD 165.64M 265K Jun/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organigram Holdings CAD 136.47M 1.34M Mar/2026
Ovoca Bio EUR 29.49M 0 Dec/2025
Pharma Mar EUR 17.34M 24.24K Jun/2026
Puma Biotechnology USD 5K 0 Jun/2024
Qiagen NV USD 206.5M 245K Jun/2026
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sarepta Therapeutics USD 105.62M 53K Jun/2026
Sartorius EUR 69.05M 0 Jun/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tilray USD 116.52M 5.01M Sep/2025
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
United Therapeutics USD 42.68M 521K Jun/2026
Vertex Pharmaceuticals USD 253.3M 900K Jun/2026
Zealand Pharma A/S 70.66M 53K Mar/2026
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026